We may feel good treating a patient's edema, but is fluid retention always harmful?
Researchers observed significant improvements in inflammation and physical function.
But more detailed genetic studies needed in the dialysis population.
Contrast-Induced Nephropathy is significantly associated with mortality and need for dialysis; hydration is also a predictor of CIN.
Investigators propose a protocol for when patients should be referred to nephrologists.
Recent meta-analysis compared continuous renal replacement therapy and extended daily dialysis.
New report shows that Montenegro had the lowest rate of renal replacement therapy.
Most staff feel that extended treatment time is clinically beneficial, but not all recommend it.
New findings add to a growing body of evidence supporting the avoidance of vitamin K antagonists in dialysis patients.
Emergency department visit and hospitalization rates increased in wake of storm.
Reducing dietary phosphorus is challenging, so researchers have developed a food pyramid for CKD and dialysis patients.
The findings generally support KDOQI guidelines for dialysis patients, which recommend maintaining serum phosphorus levels between 3.5 and 5.5 mg/dL.
Levels of at least 550 but less than 650 pg/mL are associated with a 26% increased mortality risk vs. levels below 400 pg/mL.
Better treatments, tighter management of kidney disease may explain promising trend.
Survey of nephrologists shows kidney failure becoming more common for expectant moms.
The increased risk is especially pronounced among patients with low serum albumin.
Absence of association observed in patients with normal or near-normal baseline estimated glomerular filtration rate.
Starting on peritoneal dialysis was associated with a 25% lower dementia risk versus starting on hemodialysis, a study showed.
Risk of hospitalization and modality failure is significantly lower, Canadian study finds.
Trial shows that changes to blood during storage do not affect quality.
Over a 5-year period, cancer developed in 9.5% of hemodialysis patients, a rate much higher than would be expected in the general population.
The medication may represent a new treatment option for dialysis patients, researchers concluded.
Still, approximately 70% of patients initiate dialysis with a catheter.
Lixelle Beta 2-microglobulin Apheresis Column authorized for use in DRA
Use of the medication, however, is associated with a 4-fold increased risk of bleeding.
Extranasal Staphylococcus aureus is a common cause of healthcare-associated infections in hemodialysis patients.
Soluble ferric pyrophosphate is given to hemodialysis patients via dialysate.
Investigators found that dialysis patients with serum calcium levels of 10.2 mg/dL or greater had increased risks of premature death.
Higher magnesium levels in hemodialysis patients with high phosphorus levels were associated with decreased cardiovascular mortality.
Boiling in water and stewing in an oil-water mixture were found to reduce phosphorus levels significantly in various foods.
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)